Hikma Pharmaceutical | HIK - Lucro Bruto Sobre Vendas

Preço das Ações
1,210.00
Mudança Diária
-39.00 -3.12%
Mensal
-21.43%
Anual
-44.09%
Q1 Previsão
1,287.59




Lucro Bruto Sobre Vendas Alterar Data
Almirall EUR 429.87M 180.02M 2025-12
argenx SE USD 1.14B 118.49M 2025-12
AstraZeneca USD 12.39B 5M 2025-12
Autolus Therapeutics Ltd USD -7.45M 3.93M 2025-09
Bayer EUR 5.35B 1.02B 2025-09
Fresenius EUR 1.51B 214M 2025-12
Galapagos EUR -13.57M 74.82M 2025-09
Genmab DKK 868M 195M 2025-06
GlaxoSmithKline GBP 6.18B 106M 2025-12
GRIFOLS EUR 743.8M 49.13M 2025-06
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Lonza CHF 1.29B 248M 2025-06
Merck EUR 3.21B 186M 2025-09
Orion EUR 508.7M 254.5M 2025-12
Recordati EUR 432.41M 8.56M 2025-09
Roche Holding CHF 22.09B 10.04B 2025-12
Sanofi EUR 8.45B 1.31B 2025-12
UCB EUR 2.46B 520M 2024-12